Israel Englander’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Israel Englander's AXSM Position: Q3 2026 in Review
Israel Englander increased its Axsome Therapeutics (AXSM) stake by 138% in Q3 2026, buying an estimated $167M and bringing the position to 1,323,032 shares worth $244M. The position accounts for 0.08% of the portfolio, ranked #205.
Israel Englander first reported a position in AXSM in Q4 2015 and has held it in 37 quarters since. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Israel Englander held 1,323,032 shares of Axsome Therapeutics worth $244M as of Q3 2026.
- Israel Englander bought 766,944 Axsome Therapeutics shares in Q3 2026, an estimated $167M.
- Axsome Therapeutics made up 0.08% of Israel Englander's portfolio in Q3 2026, its #205 holding.
- Israel Englander first reported a position in Axsome Therapeutics in Q4 2015 and has held it in 37 quarters since.
- 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.